In contrast to RF and ACPA, RA33 isotypes showed little overlap and therefore, despite their modest sensitivities, RA33 antibodies were seen in more than 20% of RA patients including, as mentioned above, a substantial number of seronegative ones. Here, PRTN3 is linked to rheumatoid arthritis.